Skip to main content
Premium Trial:

Request an Annual Quote

Cellular Dynamics Signs Korea Distribution Deal with SeouLin Bioscience

NEW YORK (GenomeWeb) – Human cell line manufacturer and Fujifilm subsidiary Cellular Dynamics today announced an exclusive agreement with SeouLin Bioscience for the distribution of the company's products in theRepublicofKorea.

Under the terms of the agreement, SeouLin will distribute Cellular Dynamics' iCell products, a set of tissue cell lines derived from human induced pluripotent stem cells. The iCell catalogue includes 12 cell types including cardiomyocytes, hepatocytes, and neurons, among others.

The companies said they are also discussing an expansion of the agreement to cover Cellular Dynamics' MyCell products, which include the reprogramming, genetic engineering, and differentiation of induced pluripotent stem cells to enable the manufacture of terminally differentiated cells from customers' specific donor samples.

As part of the agreement, SeouLin Bioscience will handle first-level technical support inquiries from its customers, the companies said. Financial terms of the deal were not disclosed.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.